Zotarolimus-eluting stent (Endeavor Resolute) for coronary artery disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Jan 2008: Trial registered, NCT00598637

The trials

NCT00598637: Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease

State
Completed
Phase
Phase 4
People
650 taking part
Started
Dec 2007
Primary completion
Sep 2012
Arms
ZES
Results
None posted
  1. 22 Jan 2008: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.